IFNAR1 and Autoimmunity: Nonetheless, the importance of pDC activation at early disease stages is consistent with studies suggesting that pDC depletion [74] or IFNAR blockade [83] more efficiently reduce systemic autoimmunity when applied before a critical threshold of immune activation is exceeded.